Literature DB >> 26908736

Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge.

Shinji Kasahara1, Anupam Jhingran1, Sourabh Dhingra2, Anand Salem1, Robert A Cramer2, Tobias M Hohl3.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic cytokine that plays a critical role in regulating myeloid cell host defense. In this study, we demonstrated that GM-CSF signaling plays an essential role in antifungal defense against Aspergillus fumigatus. Mice that lack the GM-CSF receptor β chain (GM-CSFRβ) developed invasive hyphal growth and exhibited impaired survival after pulmonary challenge with A. fumigatus conidia. GM-CSFRβ signaling regulated the recruitment of inflammatory monocytes to infected lungs, but not the recruitment of effector neutrophils. Cell-intrinsic GM-CSFRβ signaling mediated neutrophil and inflammatory monocyte antifungal activity, because lung GM-CSFRβ(-/-) leukocytes exhibited impaired conidial killing compared with GM-CSFRβ(+/+) counterparts in mixed bone marrow chimeric mice. GM-CSFRβ(-/-) neutrophils exhibited reduced (hydrogenated) nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity in vivo. Conversely, administration of recombinant GM-CSF enhanced neutrophil NADPH oxidase function, conidiacidal activity, and lung fungal clearance in A. fumigatus-challenged mice. Thus, our study illustrates the functional role of GM-CSFRβ signaling on lung myeloid cell responses against inhaled A. fumigatus conidia and demonstrates a benefit for systemic GM-CSF administration.
© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Aspergillus; GM-CSF; ROS; monocytes; neutrophils

Mesh:

Substances:

Year:  2016        PMID: 26908736      PMCID: PMC4799674          DOI: 10.1093/infdis/jiw054

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  Purification and properties of colony-stimulating factor from mouse lung-conditioned medium.

Authors:  A W Burgess; J Camakaris; D Metcalf
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

2.  Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors.

Authors:  A F Lopez; N A Nicola; A W Burgess; D Metcalf; F L Battye; W A Sewell; M Vadas
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

3.  Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants.

Authors:  R H Weisbart; L Kwan; D W Golde; J C Gasson
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

4.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.

Authors:  K S Antman; J D Griffin; A Elias; M A Socinski; L Ryan; S A Cannistra; D Oette; M Whitley; E Frei; L E Schnipper
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

5.  Aspergillus vertebral osteomyelitis in a child with a primary monocyte killing defect: response to GM-CSF therapy.

Authors:  L Abu Jawdeh; R Haidar; F Bitar; S Mroueh; S Akel; N Nuwayri-Salti; G S Dbaibo
Journal:  J Infect       Date:  2000-07       Impact factor: 6.072

6.  Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria.

Authors:  J Riopel; M Tam; K Mohan; M W Marino; M M Stevenson
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1.

Authors:  Y Shibata; P Y Berclaz; Z C Chroneos; M Yoshida; J A Whitsett; B C Trapnell
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

8.  Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia.

Authors:  Elmer Brummer; Marika Kamberi; David A Stevens
Journal:  J Infect Dis       Date:  2003-02-07       Impact factor: 5.226

9.  Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis.

Authors:  Brad E Morrison; Stacy J Park; Jill M Mooney; Borna Mehrad
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

10.  Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells.

Authors:  L Churchill; B Friedman; R P Schleimer; D Proud
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

View more
  28 in total

1.  Influenza Suppresses Neutrophil Recruitment to the Lung and Exacerbates Secondary Invasive Pulmonary Aspergillosis.

Authors:  Joshua M Tobin; Kara L Nickolich; Krishnaveni Ramanan; Matthew J Pilewski; Kristina D Lamens; John F Alcorn; Keven M Robinson
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

Review 2.  Immune responses to invasive aspergillosis: new understanding and therapeutic opportunities.

Authors:  Tobias M Hohl
Journal:  Curr Opin Infect Dis       Date:  2017-08       Impact factor: 4.915

3.  Lung Epithelial Cells Coordinate Innate Lymphocytes and Immunity against Pulmonary Fungal Infection.

Authors:  Nydiaris Hernández-Santos; Darin L Wiesner; J Scott Fites; Andrew J McDermott; Thomas Warner; Marcel Wüthrich; Bruce S Klein
Journal:  Cell Host Microbe       Date:  2018-03-22       Impact factor: 21.023

4.  Host response to pulmonary fungal infections: A highlight on cell-driven immunity to Cryptococcus species and Aspergillus fumigatus.

Authors:  Orchi Dutta; Jorge A Masso-Silva; Keyi Wang; Amariliz Rivera
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

5.  Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activity.

Authors:  Gloria Castellano-González; Helen M McGuire; Fabio Luciani; Leighton E Clancy; Ziduo Li; Selmir Avdic; Brendan Hughes; Mandeep Singh; Barbara Fazekas de St Groth; Giorgia Renga; Marilena Pariano; Marina M Bellet; Luigina Romani; David J Gottlieb
Journal:  Blood Adv       Date:  2020-07-28

Review 6.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

Review 7.  Menacing Mold: Recent Advances in Aspergillus Pathogenesis and Host Defense.

Authors:  Benjamin Y Tischler; Tobias M Hohl
Journal:  J Mol Biol       Date:  2019-04-04       Impact factor: 5.469

Review 8.  It takes a village: Phagocytes play a central role in fungal immunity.

Authors:  Michael B Feldman; Jatin M Vyas; Michael K Mansour
Journal:  Semin Cell Dev Biol       Date:  2018-06-12       Impact factor: 7.727

Review 9.  New advances in invasive aspergillosis immunobiology leading the way towards personalized therapeutic approaches.

Authors:  Joshua J Obar; Tobias M Hohl; Robert A Cramer
Journal:  Cytokine       Date:  2016-05-30       Impact factor: 3.861

Review 10.  Immunity against fungi.

Authors:  Michail S Lionakis; Iliyan D Iliev; Tobias M Hohl
Journal:  JCI Insight       Date:  2017-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.